Perritt Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-400
Closed -$280K 188
2020
Q2
$280K Sell
400
-300
-43% -$173K 0.21% 124
2020
Q1
$245K Sell
700
-810
-54% -$574K 0.2% 132
2019
Q4
$949K Sell
1,510
-700
-32% -$342K 0.46% 64
2019
Q3
$741K Hold
2,210
0.31% 93
2019
Q2
$574K Buy
2,210
+1,210
+121% +$242K 0.23% 128
2019
Q1
$165K Buy
+1,000
New +$163K 0.06% 215

Other funds holding CDLX

Perritt Capital Management's CDLX Position: Q3 2020 in Review

Perritt Capital Management sold out of Cardlytics (CDLX) in Q3 2020, closing a stake of 400 shares — an estimated $280K sold.

Perritt Capital Management first reported a position in CDLX in Q1 2019 and held it in 6 quarters. The position peaked at $949K in Q4 2019. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2020.

  • Perritt Capital Management reported no remaining Cardlytics position as of Q3 2020 after selling out during the quarter.
  • Perritt Capital Management sold 400 Cardlytics shares in Q3 2020, an estimated $280K.
  • Perritt Capital Management first reported a position in Cardlytics in Q1 2019 and held it in 6 quarters.
  • Perritt Capital Management's Cardlytics position peaked at $949K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2020.

Based on Perritt Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.